CD28 Costimulation Provided through a CD19-Specific Chimeric Antigen Receptor Enhances<i>In vivo</i>Persistence and Antitumor Efficacy of Adoptively Transferred T CellsClaudia Kowolik, Laurence J.N. Cooper, Simon Olivares et al.|Cancer Research|2006Cited by 487
In vivo delivery of siRNA to immune cells by conjugation to a TLR9 agonist enhances antitumor immune responsesMarcin Kortylewski, Hua Yu, Piotr Swiderski et al.|Nature Biotechnology|2009Cited by 378